• Explore /
  • Poster
  • / A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), <em>RAS</em> wild-type (<em>RAS</em>-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442).

A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442).

Abstract Video & Slides Poster

Authors

Christopher Williams

Christopher Williams

Leeds Cancer Centre, Leeds, United Kingdom

Christopher Williams , Jake Emmerson , Andrew David Beggs , Nicholas West , John A. Bridgewater , Janet Graham , Matthew T. Seymour , Gemma Hemmings , Claire Dimbleby , Geraldine A Murden , Alexandra Gilbert , David M. Meads , David A. Cairns , Richard Adams , Jenny F. Seligmann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

11061442

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS3633)

DOI

10.1200/JCO.2022.40.16_suppl.TPS3633

Abstract #

TPS3633

Poster Bd #

424b

Abstract Disclosures

Similar Posters

First Author: Christopher Williams

First Author: Marc Van Den Eynde

First Author: Richard Adams

First Author: Richard A. Adams